SOURCES SOUGHT
A -- Request for Information - Technology Exhibiting Narrow-Spectrum Activity to Target Prevention of Urinary Tract Infections
- Notice Date
- 1/15/2016
- Notice Type
- Sources Sought
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of the Army, Army Contracting Command, ACC - APG (W911QY) Natick (SPS), BLDG 1 KANSAS ST, Natick, Massachusetts, 01760-5011, United States
- ZIP Code
- 01760-5011
- Solicitation Number
- W911QY16XXX03
- Point of Contact
- Jennifer Rego, Ph.D., Phone: 508-233-4727
- E-Mail Address
-
jennifer.m.rego.civ@mail.mil
(jennifer.m.rego.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- The US Army Natick Soldier, Research, Development, and Engineering Center (NSRDEC) is requesting concept papers that address the prevention of urinary tract infections (UTIs) to be proposed under the NSRDEC's Broad Agency Announcement for Basic and Applied Research, Solicitation Number W911QY-15-R-0016 under section VI - Scientific and Technical Areas of Interest, Part C. Warfighter Systems Technologies, Topic Area 6, Biotechnology. The technology should specifically target pathogenic bacteria that cause UTIs while rendering the commensal microflora unaffected. The technology may take the form for use as or development of a hygiene wipe by the Warfighter in the field to prevent the inception of UTIs. The technology should be comprised of a solution-based foundation that includes an agent that exhibits narrow-spectrum activity against UTI causing bacteria, components to enhance stability as well as a wipe textile to serve as the technology platform. The technology should be evaluated for its range of activity against UTI causing pathogenic bacteria as well as commensal bacteria, propensity of microorganisms to develop resistance towards it, and the stability of the agent over time. Concept papers should include generalized information to initiate discussions for potential proposal submission for award of a multi-phased research and development contract. These papers should include a description of your efforts to develop narrow-spectrum technology that specifically targets the pathogenic bacteria that cause UTIs and demonstrates no activity against the vaginal commensal bacteria. Any results arising from your efforts should be summarized and included in the concept paper to demonstrate the intended action and behavior of the technology. Comprehensive technologies not based on an aqueous solution, such as creams and ointments, will not be considered. However, the active agent in the cream or ointment may be considered for development in a solution. Technologies in varying phases of development will be considered. These may include an individual agent or agents that demonstrate targeted activity against UTI causing microorganisms, a solution-based formulation that incorporates the agent(s) with stabilizing additives to maintain robust activity during long-term storage, and/or a comprehensive technology construct comprised of the agent, solution components and a wipe textile. Concept papers may also describe ideas or provide propositions concerning the development of the aforementioned technology. Respondents should describe in their concept papers their technologies and identify how their technology offers a level of protection against UTI causing bacteria toward prevention of the infection. Information may include, but is not limited to: technical test data (e.g. physical properties/performance characteristics), test methodology, level of activity against pathogenic UTI causing bacteria, level of activity against vaginal commensal microflora, characterized thermal stability, status and specifications for manufacturing and production, any unique or proprietary construction requirements related to the technology, costs, relevant company background & experience, personnel, patents, a sample (optional), and any other information that the respondent believes demonstrates the value of their technologies and the ability to meet the aforementioned desired performance. Firms responding shall indicate whether or not they are a small business. Any information/samples submitted will not be returned. If a firm chooses to submit samples, no payment will be made by the Government for such samples. Concept papers may include a list of potential contract deliverables including, but not limited to: agent(s), active solution formulation and/or comprehensive technology developed into a wipe that targets prevention of UTIs by exhibiting narrow-spectrum activity against pathogenic UTI causing bacteria while not affecting the viability of vaginal commensal microorganisms for evaluation; technical progress reports and a complete scientific report detailing all development work and findings to include characterization of the agent and, when applicable, solution formulations and component identification and concentration ratios; processing techniques to achieve the final result of each delivered technology. While there is no guarantee that ensuing solicitation will be issued and/or a contract awarded, currently, it is the government's preference and intention to obtain at least government purpose rights in all deliverables created, generated or produced under any contract effort. The findings from this Market Research effort may impact future solicitations related to this requirement. This Market Research is not a solicitation as defined by FAR 2.101, and the Government is not requesting offers for proposals at this time. This is a Request for Information and does not constitute a solicitation or request for proposal. This is a market survey for planning purposes. Responses to this request for concept papers are not offers and cannot be accepted by the Government to form a binding contract. If a solicitation is issued, the Government does not guarantee that it will be issued to RFI respondents. All information received in response to this request for concept papers that is marked proprietary will be handled accordingly. Capability Statements, including attachments, are limited to ten (10) pages. Responses should be submitted in MS WORD and/or MS Excel or PDF, including attachments. Interested sources shall include information regarding a firm's experience, personnel, and facilities. Any information/samples submitted will not be returned, and no payment will be made by the government for such information/samples. Any testing results will be controlled and used for governmental purposes only. THIS IS NOT A REQUEST FOR PROPOSAL. No telephonic submissions will be honored. All product information shall be submitted at no cost or obligation to the Government. Interested parties should respond by April 15, 2016. Questions and responses to this notice are to be sent to Dr. Jennifer Rego at jennifer.m.rego.civ@mail.mil or mailed to Jennifer Rego, Natick Soldier RD&E Center, 15 General Greene Avenue, Building 3, R-343 Natick, MA 01760.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/f577ab013e27961968a20e3ebdf0316f)
- Place of Performance
- Address: Natick Soldier Research, Development and Engineering Center, 10 General Greene Ave, Natick, Massachusetts, United States
- Record
- SN03994104-W 20160117/160115234346-f577ab013e27961968a20e3ebdf0316f (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |